AKINSEAKI India LimitedHighNeutral
Announced Thu, 12 Feb · 18:06 IST

Integrated Filing (Financial) for the Quarter and Nine Month ended on 31st December, 2025

Revenue Growth 20pctRevenue DeclinePat Growth 25pctExceptional ItemEbitda Margin CompressionResults View source PDF

AKI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

AKI India submitted its integrated financial results for Q3 and 9M FY26. On a standalone basis, the picture is weak: Q3 net sales fell about 39% YoY to Rs 1,329.50 lakh and 9M sales fell about 17% to Rs 4,303.87 lakh. Standalone Q3 profit dropped to Rs 7.81 lakh from Rs 18.93 lakh, with 9M profit at Rs 66.97 lakh versus Rs 86.01 lakh a year ago. On a consolidated basis, including subsidiary AKI UK and JV AKI Castil Shoes LLP, 9M revenue grew about 24% to Rs 7,074.88 lakh and 9M profit rose about 36% to Rs 210.00 lakh, with Q3 profit up to Rs 109.01 lakh from Rs 71.91 lakh. The statutory auditor (R K Parmarthi & Co) issued an unqualified limited review report on both standalone and consolidated results. The prior 9M period included an exceptional/extraordinary item of Rs 82.64 lakh, which partly explains the headline year-on-year PBT drop on a standalone basis.

Likely market impact

The gap between declining standalone leather business and growing consolidated numbers shows the parent company is leaning on its UK subsidiary and JV for growth, which is positive but raises concentration risk. Investors should watch whether the core standalone leather segment stabilises; short-term consolidated growth and EPS improvement are supportive, but standalone weakness is a concern.